The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry
Authors:
- 1 October 2018
- journal article
- editorial
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 24 (10) , 706-710
Abstract
No abstract availableKeywords
Funding Information
- Boston Scientific Corporation
This publication has 10 references indexed in Scilit:
- Acute mechanical circulatory support for cardiogenic shock: the “door to support” timeF1000Research, 2017
- Giant Cell Myocarditis Masquerading as Orbital Myositis with a Rapid, Fulminant Course Necessitating Mechanical Support and Heart TransplantationESC Heart Failure, 2017
- The Quest for New Approaches in Myocarditis and Inflammatory CardiomyopathyJACC, 2016
- Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patientsJournal of Thoracic Disease, 2016
- Heart Transplantation Under Mechanical Circulatory Support for Acute Fulminant Myocarditis With Cardiogenic ShockTransplantation Proceedings, 2016
- Hemodynamic Support with Percutaneous Devices in Patients with Heart FailureHeart Failure Clinics, 2015
- Acute Mechanical Circulatory Support for Fulminant Myocarditis Complicated by Cardiogenic ShockJournal of Cardiovascular Translational Research, 2014
- Regression of Inflammation in the Failing Human Heart after Continuous Flow Left Ventricular Assist Device-Induced Mechanical Unloading?The Journal of Heart and Lung Transplantation, 2013
- Combined Use of Impella Left Ventricular Assist Device and Extracorporeal Membrane Oxygenation as a Bridge to Recovery in Fulminant MyocarditisASAIO Journal, 2012
- A Clinical Trial of Immunosuppressive Therapy for MyocarditisNew England Journal of Medicine, 1995